The page is the record's research on the issuer — no analyst, no rating, no view. # enGene Therapeutics Inc. (NASDAQ: ENGNW) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is enGene Therapeutics Inc., listed on NASDAQ under ticker ENGNW, with ISIN US29286X1191. The LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-Z4 exists. The security type is Corporate, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is Canada (Federal Level). The segment is not on the record. The issuer is listed, not halted. ## The disclosure read The record holds 67 filings across 33 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 5.0 days. The latest filing is dated 2026-09-24, a directors_dealings filing, which is 45 days before the record date of 2026-11-08. The NASDAQ exchange median is 52 filings, a cadence gap of 6.0 days, and latency of 5.0 days across 4359 issuers. The sector median is 65.5 filings, a cadence gap of 5.5 days, and latency of 4.0 days across 176 issuers. The filings by type are: regulatory_filing 22, directors_dealings 19, results 9, corporate_news 8, prospectus 4, director_change 3, and agm_egm 2. ## Auditor The auditor of record is KPMG LLP, located in Montreal, Canada. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting, name change or segment move lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found on the record. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer is sealed for the years 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. The market's vintage is sealed. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001980845.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/ENGNW (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1980845/000119312525328743/engn-20251031.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ENGNW (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ENGNW · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp